Temasek Polytechnic and NexTech BioPharma have signed an MOU, formalising a strategic partnership that aims to facilitate R&D in stem cell therapy, and/or other related medical sciences. This includes working on joint research projects and grant applications. The collaboration also covers skills training of TP staff and students in current Good Manufacturing Practice (cGMP) and clean room operations.

The MOU was signed by Mr Peter Lam, TP’s Principal & CEO, and NexTech’s signatory was Mr Kunio Yamada, Chairman & CEO, Rohto Pharmaceutical.